Preoperative evaluation of tumor extension in patients with recurrent cervical cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 5, 1997, Pages 474-477

  Zeisler, Harald ^a   Joura, Elmar Armin ^a   Moeschl, Peter ^a   Maier, Ulrich ^a   Koelbl, Heinz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cervical cancer; Pelvic exenteration; Recurrent disease

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS PYELOGRAPHY; LYMPH NODE; PATIENT SELECTION; PELVIS EXENTERATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTOSCOPY; RECTUM; UTERINE CERVIX CANCER;

EID: 0030913022     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709047831     Document Type: Article

References (19)

1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948; 1: 177-83.
2. Symmonds RE, Pratt JH, Webb MJ. Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 1975; 125: 609-16.
3. Rutledge FN, Smith JP, Wharton JT, O'Quinn AG. Pelvic exenteration: Analysis of 296 patients. Am J Obstet Gynecol 1977; 129: 881.
4. Morley GW, Lindenauer SM. Pelvic exenterative therapy for gynecologic malignancy. Cancer 1976; 38: 581.
5. Stanhope CR, Symmonds RE. Palliative exenteration - what, when and why? Am J Obstet Gynecol 1985; 152: 12-16.
6. Singleton HAM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989; 73: 1027-34.
7. Hervy EA, Lichtinger M, Sevin BU, Girtanner RE. Pelvic exenteration: A 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 1984; 150: 179.
8. Girtanner RE, DeCampo T, Alleyn JN, Averette HE. Routine intensive care for pelvic exenterative operations. Surg Gynecol Obstet 1981; 153: 657.
9. Robertson G, Lopes A, Beynon G, Monaghan JM. Pelvic exenteration: A review of the Gateshead experience 1974-1992. Br J Obstet Gynaecol 1994; 101(6): 529-31.
10. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 patients in 5 years. Obstet Gynecol 1989; 74: 934-43.
11. Rutledge FN, McGuffee VB. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol 1987; 26: 374-80.
12. Barber HRK, Jones W. Lymphadenectomy in pelvic exenteration for recurrent cervix cancer. JAMA 1971; 215: 1945.
13. Hopkins MP, Morley GW. Pelvic exenteration for the treatment of the vulvar cancer. Cancer 1992; 70: 2835-8.
14. Jones WB. Surgical approaches for advanced or recurrent cancer of the cervix. Cancer 1987; 60: 2094.
15. Morley GW, Lindenauer SM, Cerny JC. Pelvic exenterative therapy in recurrent pelvic carcinoma. Am J Obstet Gynecol 1971; 109: 1175.
16. Manetta A, Podczaski ES, Larsen JE, De Geest K, Mortel R. Scalene lymph node biopsy in the preoperative evaluation of patients with recurrent cervical cancer. Gynecol Oncol 1989; 33: 332-4.
17. Plukker Th, Aalders G, Mensink JA, Oldhoff J. Total pelvic exenteration: a justified procedure. Br J Surg 1993; 80: 1615-17.
18. Jakowatz JG, Porudominsky D, Riihimaki DU, Kemeny M, Kokal WA, Braly PS et al. Complications of pelvic exenteration. Arch Surg 1985; 120(11): 1261-5.
19. Orr JW Shingleton HM, Hatch KD, Taylor PT, Partridge EE, Soong SJ. Gastrointestinal complications associated with pelvic exenteration. Am J Obstet Gynecol 1983; 145: 325.